THE ASSOCIATION BETWEEN PSA DENSITY AND THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER ACROSS ALL PIRADS SCORES IN MEN WITH POSITIVE MPMRI. WHEN PSA DENSITY CAN HELP AVOIDING PROSTATE BIOPSY?

被引：0
|
作者：
Pellegrino, Francesco
Gandaglia, Giorgio
Stabile, Armando
Cucchiara, Vito
Bandini, Marco
Mazzone, Elio
Rosiello, Giuseppe
Sorce, Gabriele
Pellegrino, Antony
Longoni, Mattia
Scilipoti, Pietro
Quarta, Leonardo
Zaurito, Paolo
Fossati, Nicola
Zaffuto, Emanuele
Deho, Federico
De Cobelli, Francesco
Brembilla, Giorgio
Montorsi, Francesco
Briganti, Alberto
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD39-10
引用
收藏
页码：E1049 / E1049
页数：1
相关论文
共 30 条
  • [1] Predictors of clinically significant prostate cancer: does PSA density relate to PIRADS on multiparametric MRI?
    Mare, A.
    Jyoti, R.
    Haxhimolla, H.
    BJU INTERNATIONAL, 2016, 117 : 96 - 97
  • [2] Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI
    Ma, Zengni
    Wang, Xinchao
    Zhang, Wanchun
    Gao, Kaisheng
    Wang, Le
    Qian, Lixia
    Mu, Jingjun
    Zheng, Zhongyi
    Cao, Xiaoming
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [3] Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI
    Zengni Ma
    Xinchao Wang
    Wanchun Zhang
    Kaisheng Gao
    Le Wang
    Lixia Qian
    Jingjun Mu
    Zhongyi Zheng
    Xiaoming Cao
    World Journal of Surgical Oncology, 21
  • [4] Association between PSA density and prostate cancer in men without significant MRI lesions
    Mortezavi, Ashkan
    Eklund, Martin
    Bergman, Martin
    Kjosavik, Svein R.
    Discacciati, Andrea
    Nordstrom, Tobias
    BJU INTERNATIONAL, 2020, 125 (06) : 763 - 764
  • [5] Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume
    Omri, Nativ
    Kamil, Malshy
    Alexander, Kastin
    Alexander, Kravtzov
    Edmond, Sabo
    Ariel, Zisman
    David, Kakiashvili
    Gilad, Amiel E.
    Azik, Hoffman
    PROSTATE, 2020, 80 (16): : 1444 - 1449
  • [6] CLINICAL UTILITY OF PSA DENSITY AND PI-RADS FOR DEFERRING BIOPSY FOR THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER
    Truong, Matthew
    Stevens, Erica
    Ward, Ryan
    Bullen, Jennifer
    Austhof, Ethan
    Valdez, Rogelio
    Purysko, Andrei
    Klein, Eric
    JOURNAL OF UROLOGY, 2020, 203 : E1104 - E1104
  • [7] Clinical utility of PSA density and PI-RADS for deferring biopsy for the detection of clinically significant prostate cancer
    Truong, Matthew
    Stevens, Erica
    Ward, Ryan
    Bullen, Jennifer
    Austhof, Ethan
    Valdez, Rogelio
    Purysko, Andrei
    Klein, Eric A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [8] CLINICALLY SIGNIFICANT PROSTATE CANCER DETECTION RATES IN PI-RADS 3 LESIONS ON MPMRI: RISK STRATIFIED BY PSA DENSITY
    Huang, Karen
    Ou, Michelle
    Chaudhary, Sarah
    Hall, Simon J.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E313 - E313
  • [9] PSA DENSITY (PSAD) ALONE OR WITH MULTIPARAMETRIC MRI (MPMRI) IS ROBUST AT PREDICTING CLINICALLY SIGNIFICANT PROSTATE CANCER (CSPCA)
    Pandya, Shashank S.
    Andreas, Darian
    Nethala, Daniel
    Lee, Jeffrey
    Hall, Simon J.
    JOURNAL OF UROLOGY, 2021, 206 : E506 - E506
  • [10] Performance of prostate health index and PSA density in a diverse biopsy-naïve cohort with mpMRI for detecting significant prostate cancer
    Carbunaru, Samuel
    Stinson, James
    Babajide, Rilwan
    Hollowell, Courtney M. P.
    Yang, Ximing
    Sekosan, Marin
    Ferrer, Karen
    Kajdacsy-Balla, Andre
    Abelleira, Josephine
    Ruden, Maria
    King-Lee, Patrice
    Dalton, Daniel P.
    Casalino, David D.
    Kittles, Rick A.
    Gann, Peter H.
    Schaeffer, Edward M.
    Murphy, Adam B.
    BJUI COMPASS, 2021, 2 (06): : 370 - 376
123